- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ipsos Healthcare Receives Award from Personal Connected Health Alliance
Ipsos Healthcare, the global healthcare division of Ipsos, has been given the New Member Award by the Personal Connected Health Alliance (PCHAlliance). PCHAlliance–a non-profit organization which mobilizes stakeholders to realise the full potential of personal connected health–presented Ipsos with the award at the Fall Member Summit yesterday, an event co-located with its 9th Annual Connected Health Conference in Boston, MA. The award was received by Ipsos Healthcare’s Head of Connected Health, Reena Sangar. Commenting on its decision to recognise Ipsos, PCHAlliance said, “In its first year as a member of PCHAlliance, Ipsos Healthcare has contributed significantly to the Alliance’s efforts through its Global Connected Health Survey, Digital Doctor Survey, and new efforts related to Digital Therapeutics. Ipsos is also exploring cutting-edge approaches to studying behaviours related to personal connected health that can inform a push towards sustained use of technology.”
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Efsitora Demonstrates Non-Inferiority vs. Insulin Glargine, Degludec for Type 2 Diabetes
September 5th 2024Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec.
